Cancer: Crosetto's Breakthrough Inventions with Potential to Save Millions of Lives and Billions of Dollars Approved for a Two-Hour Presentation at IEEE

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Crosetto-Cancer

More Like This

Only Transparency and Accountability Can Save CERN: Stop Billions in Waste, Unlock Life-Saving Innovations

PR Newswire associated0

Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response

The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the platform features three complexity levels: standard (cancer cells), intermediate (+fibroblasts), and advanced (+immune/endothelial cells) . A key breakthrough is its record cellular viability of 128 days, enabling unprecedented long-term studies on drug resistance and metastasis . Ultimately, CTIONCOTEST delivers a highly predictive, 100% human-derived ethical alternative to animal testing.

Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care

Together with Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway

New Government tech deals boost the business of cancer detection

PR Newswire associated0

BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES